GenePeeks names new chair
This article was originally published in Scrip
Executive Summary
Lifeprint Group, the parent company for GenePeeks – a genetic information company focused on next-generation disease risk analysis – has named Mara Aspinall executive chair of its board of directors. Ms Aspinall is the former president and CEO of Ventana Medical Systems. Vertana is a member of the Roche Group and a leader in the development, manufacture and commercialization of tissue-based cancer diagnostics that enable the delivery of personalized healthcare to patients. Previously, Ms Aspinall spent 12 years with Genzyme, where she held leadership roles that included president of Genzyme Genetics and president of Genzyme Pharmaceuticals.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.